
Theravance Biopharma TBPH
$ 16.57
-0.6%
Annual report 2025
added 03-23-2026
Theravance Biopharma DIO Ratio 2011-2026 | TBPH
Annual DIO Ratio Theravance Biopharma
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 1.02 K | 1.54 K | 784 | 1.13 K | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.54 K | 784 | 1.12 K |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
239 | $ 9.33 | 1.41 % | $ 603 M | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
4.89 | $ 0.87 | -2.13 % | $ 6.4 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
295 | $ 22.38 | 0.81 % | $ 3.71 B | ||
|
Galapagos NV
GLPG
|
0.915 | $ 28.15 | 1.04 % | $ 2.69 B | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 8.22 | 3.92 % | $ 6.83 B | ||
|
Harmony Biosciences Holdings
HRMY
|
11.6 | $ 30.95 | -0.34 % | $ 1.78 B | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
ImmuCell Corporation
ICCC
|
185 | $ 8.43 | -0.12 % | $ 76.1 M | ||
|
Incyte Corporation
INCY
|
78.4 | $ 98.55 | -0.55 % | $ 19.2 B | ||
|
InMed Pharmaceuticals
INM
|
309 | $ 0.71 | 1.27 % | $ 1.74 M | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Jaguar Health
JAGX
|
916 | $ 7.34 | -6.79 % | $ 17.1 M | ||
|
KalVista Pharmaceuticals
KALV
|
203 | $ 26.68 | 0.02 % | $ 1.44 B | ||
|
Kamada Ltd.
KMDA
|
166 | $ 8.16 | 0.68 % | $ 260 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
235 | $ 220.06 | -2.13 % | $ 4.02 B | ||
|
Aquestive Therapeutics
AQST
|
120 | $ 4.08 | 0.62 % | $ 436 M | ||
|
Arcutis Biotherapeutics
ARQT
|
185 | $ 23.15 | 3.49 % | $ 2.95 B |